Framatome and Exelon step up supply of Cobalt-60


Framatome and Exelon Generation announced on December 23 the signing of a memorandum of understanding to develop solutions for the production of Cobalt-60 in pressurized water reactors (PWRs) operated by Exelon Generation.

“With a decades-long commitment to the production of radioisotopes for the treatment of cancer, we understand the need for diverse, reliable and sustainable supply chains to meet market and societal expectations,” said François Gauché , director of Framatome Healthcare. “With this partnership, we want to extend our support for the sterilization of critical surgical equipment and the treatment of cancer in medical facilities around the world.”

As part of the MoU, the two companies will cooperate in technological development and assess the feasibility and economics of producing cobalt-60 in PWR reactors for industrial and medical purposes as long-term demand continues to grow. grow.

“Exelon Generation and Framatome are long-standing partners and we are proud to continue to bring together economical and reliable solutions from the nuclear industry to also support the development of critical supplies in the health sector”, declared Frédéric Lelièvre , General manager. Vice President of Sales, Regional Platforms and the I&C Business Unit of Framatome.

Framatome Healthcare, a new member of the Framatome family of brands, is committed to developing products and services for the healthcare industry. Framatome said his team supports the value chain of radioisotopes used in radiopharmaceuticals for diagnostic and therapeutic imaging purposes, supplies special alloys for the development of surgical implants and prostheses, and provides advanced solutions for complex sterilization facilities essential to the use of medical equipment. Framatome Healthcare experts advance cancer treatments and medical applications of nuclear technology.

Exelon Generation operates America’s largest fleet of zero-carbon nuclear power plants from 21 reactors across 12 facilities in Illinois, Maryland, New York and Pennsylvania.

Photo: Source of cobalt-60 in a sterilization facility (Credit: Framatome)

Source link


Comments are closed.